The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Nasal Drug Delivery Technology Market Between 2026 And 2030?
The nasal drug delivery technology market has experienced substantial growth in recent years. It is anticipated to expand from $85.23 billion in 2025 to $92.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be attributed to the increasing prevalence of respiratory and neurological disorders, the greater adoption of non-invasive drug delivery routes, the expansion of nasal allergy treatments, the availability of straightforward self-administration devices, and a rising acceptance of nasal therapeutics.
The nasal drug delivery technology market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $129.23 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period stems from several factors, including escalating investments in central nervous system (CNS) drug development, a heightened demand for therapies with quick onset, an expansion in nasal vaccine research, the increasing uptake of patient-friendly delivery systems, and ongoing advancements in nasal formulation technologies. Key trends during this period are expected to encompass a greater adoption of nasal spray drug formulations, an intensified focus on brain-targeted drug delivery, the evolving creation of new nasal drug devices, the broadening of vaccine and emergency therapeutic uses, and a stronger emphasis on achieving rapid drug absorption.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10037&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Nasal Drug Delivery Technology Market?
The growing occurrence of chronic illnesses is projected to fuel the expansion of the nasal drug delivery technology market in the future. Chronic diseases are long-term health conditions persisting for a year or more, requiring continuous medical intervention and often impairing daily functioning and overall quality of life. The rise in the prevalence of these diseases is influenced by aging populations, sedentary habits, and increased exposure to environmental risk factors, all of which underscore the need for more effective and user-friendly therapeutic delivery systems. Nasal drug delivery technologies contribute to improved treatment outcomes by offering a noninvasive, rapid-acting, and efficient pathway for administering medications, particularly beneficial for chronic rhinosinusitis and other persistent airway conditions that demand targeted nasal absorption and enhanced mucociliary clearance. For instance, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing incidence of chronic diseases is stimulating the growth of the nasal drug delivery technology market.
Which Market Segments Are Examined In The Nasal Drug Delivery Technology Market Study?
The nasal drug delivery technology market covered in this report is segmented –
1) By Dosage Form: Nasal Spray, Nasal Drops, Nasal Gels And Ointments, Nasal Powders, Other Dosage Forms
2) By Container Type: Pressurized Containers, Non-Pressurized Containers
3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis, Nasal Congestion, Vaccination, Other Therapeutic Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Home Care Settings, Hospitals
Subsegments:
1) By Nasal Spray: Metered-Dose Spray, Non-Metered-Dose Spray
2) By Nasal Drops: Liquid Nasal Drops, Gel-Based Nasal Drops
3) By Nasal Gels and Ointments: Hydrogel Formulations, Oil-Based Ointments
4) By Nasal Powders: Dry Powder Inhalers (DPI), Spray-Dried Powders
5) By Other Dosage Forms: Nasal Patches, Nasal Inserts
Which Trends Are Influencing The Nasal Drug Delivery Technology Market?
Leading companies in the nasal drug delivery technology market are focusing on the cooperative creation of technologically advanced products, like nasal powder delivery devices, to enhance precision, usability, and therapeutic efficacy, underscoring a strategic emphasis on innovation within the nasal drug delivery sector. A nasal powder delivery device is a technology designed to administer powdered medications via the nasal route, enabling targeted drug delivery for local, systemic, or nose-to-brain uses. For example, in November 2023, Hovione LLC., a pharmaceutical company from Portugal that specializes in the contract development and manufacturing of active pharmaceutical ingredients (APIs) and drug product intermediates, collaborated with Industrial Design Consultancy (IDC), a UK-based product design and development firm. Their aim was to develop innovative nasal powder delivery device technology for local, systemic, and nose-to-brain drug delivery, intending to accelerate the development and release of two novel active nasal powder delivery devices—one single-use and one multidose. These devices offer versatile and precise options for nasal deposition, ensuring optimal usability and reliability. They also have the potential to streamline drug product development and manufacturing processes through their compatibility with standard capsules and filling equipment. Hovione will be the sole provider of these devices as part of its comprehensive solution for nasal drug development and manufacturing.
Who Are The Primary Competitors In The Nasal Drug Delivery Technology Market?
Major companies operating in the nasal drug delivery technology market are AptarGroup Inc., Becton Dickinson and Company, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Company, Cadila Healthcare Limited, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., ENT Technologies Pty Ltd, Merck & Co Inc, Sanofi SA, AstraZeneca plc, Boehringer Ingelheim International GmbH, Bayer AG, Abbott Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Roche Holding AG, Allergan plc
Read the full nasal drug delivery technology market report here:
What Are The Leading Geographic Regions In The Nasal Drug Delivery Technology Market?
North America was the largest region in the nasal drug delivery technology market in 2025. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Nasal Drug Delivery Technology Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10037&type=smp
Browse Through More Reports Similar to the Global Nasal Drug Delivery Technology Market 2026, By The Business Research Company
Intranasal Drug Delivery Devices Market Report 2026
Microneedle Drug Delivery Systems Market Report 2026
Pharmaceutical Drug Delivery Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model